Seer
Proteomics company pioneering new technologies to decode the secrets of the proteome and enable early disease detection. Publicly traded on NASDAQ (SEER). Developed the Proteograph platform for deep proteome analysis.
Website
https://www.seer.bioLocation
Redwood City, California, USA
Founded
2017
Investors
1
Categories
proteomics, biomarkers, life-sciences, diagnostics, public-company
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| aMoon | Tel Aviv, Israel | biotech-focused | series-aseries-b+2 | 8 |